Zurich Cantonal Bank
TTPH

Zurich Cantonal Bank’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Zurich Cantonal Bank’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-15
Closed -$1K – 2575
2016
Q1 		$1K Hold
15
– – ﹤0.01% 2559
2015
Q4 		$3K Hold
15
– – ﹤0.01% 2557
2015
Q3 		$2K Buy
15
+10
+200% +$7.34K ﹤0.01% 2442
2015
Q2 		$5K Hold
5
– – ﹤0.01% 1981
2015
Q1 		$4K Buy
+5
New +$3.76K ﹤0.01% 2066

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Zurich Cantonal Bank's TTPH Position: Q2 2016 in Review

Zurich Cantonal Bank sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2016, closing a stake of 15 shares — an estimated $1K sold.

Zurich Cantonal Bank first reported a position in TTPH in Q1 2015 and held it in 5 quarters. The position peaked at $5K in Q2 2015. 91 funds tracked by Wall St. Rank hold TTPH as of Q2 2016.

  • Zurich Cantonal Bank reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • Zurich Cantonal Bank sold 15 Tetraphase Pharmaceuticals, Inc. shares in Q2 2016, an estimated $1K.
  • Zurich Cantonal Bank first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2015 and held it in 5 quarters.
  • Zurich Cantonal Bank's Tetraphase Pharmaceuticals, Inc. position peaked at $5K in Q2 2015.
  • 91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2016.

Based on Zurich Cantonal Bank's 13F filing for Q2 2016, filed 1 Aug 2016.